Atara Biotherapeutics Stock Price on October 22, 2024
| ATRA Stock | USD 18.00 1.65 10.09% |
If you're considering investing in Atara Stock, it is important to understand the factors that can impact its price. As of today, the current price of Atara Biotherapeutics stands at 18.00, as last reported on the 7th of January, with the highest price reaching 18.70 and the lowest price hitting 16.36 during the day. Atara Biotherapeutics is slightly risky given 3 months investment horizon. Atara Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.23, which signifies that the company had a 0.23% return per unit of standard deviation over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.6% are justified by taking the suggested risk. Use Atara Biotherapeutics risk adjusted performance of 0.1976, and Mean Deviation of 5.2 to evaluate company specific risk that cannot be diversified away.
Atara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Atara |
Sharpe Ratio = 0.2333
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ATRA | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.85 actual daily | 60 60% of assets are less volatile |
Expected Return
| 1.6 actual daily | 31 69% of assets have higher returns |
Risk-Adjusted Return
| 0.23 actual daily | 18 82% of assets perform better |
Based on monthly moving average Atara Biotherapeutics is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Atara Biotherapeutics by adding it to a well-diversified portfolio.
Related Headline
Apellis Pharmaceuticals Headline on 22nd of October 2024
Apellis Pharmaceuticals to Host Conference Call on November ... by finance.yahoo.com
WALTHAM, Mass., Oct. 22, 2024 -- Apellis Pharmaceuticals, Inc. today announced that the company will host a conference call and webcast to discuss its third quarter 2024 financial results on Tuesday, November 5, 2024, at 830 a.m. ET. To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the Events and Presentations page of the Investors and Media section
Atara Biotherapeutics Valuation on October 22, 2024
It is possible to determine the worth of Atara Biotherapeutics on a given historical date. On October 22, 2024 Atara was worth 9.15 at the beginning of the trading date compared to the closed value of 9.05. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Atara Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Atara Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Atara Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Atara Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 9.30 | 9.40 | 8.68 | 9.27 | 137,190 | |
10/22/2024 | 9.15 | 9.43 | 8.78 | 9.05 | 58,363 |
| 9.00 | 9.00 | 8.45 | 8.47 | 74,575 |
| Backtest Atara Biotherapeutics | | | Atara Biotherapeutics History | | | Atara Biotherapeutics Valuation | Previous | Next |
Atara Biotherapeutics Trading Date Momentum on October 22, 2024
| On October 23 2024 Atara Biotherapeutics was traded for 8.47 at the closing time. The top price for the day was 9.00 and the lowest listed price was 8.45 . The trading volume for the day was 74.6 K. The trading history from October 23, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 6.41% . The overall trading delta against the current closing price is 0.55% . |
Atara Biotherapeutics Fundamentals Correlations and Trends
By evaluating Atara Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Atara Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Atara financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Atara Biotherapeutics Stock history
Atara Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Atara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Atara Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Atara Biotherapeutics stock prices may prove useful in developing a viable investing in Atara Biotherapeutics
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Atara Biotherap operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 578 people.
Atara Biotherapeutics Stock Technical Analysis
Atara Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Atara Biotherapeutics Period Price Range
Low | January 7, 2025
| High |
0.00 | 0.00 |
Atara Biotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Atara Biotherapeutics January 7, 2025 Market Strength
Market strength indicators help investors to evaluate how Atara Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Atara Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Atara Biotherapeutics stock market strength indicators, traders can identify Atara Biotherapeutics entry and exit signals to maximize returns
Atara Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Atara Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Atara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Atara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1976 | |||
| Jensen Alpha | 1.59 | |||
| Total Risk Alpha | 1.44 | |||
| Sortino Ratio | 0.3148 | |||
| Treynor Ratio | 8.52 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Atara Stock analysis
When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |